Skip to main content
Access Resources

MJFF Publications

3361 - 3370 of 7540 Results
Title
Year
  • Year
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • RESTRICTED
    Title: 18F-flortaucipir PET to autopsy comparisons in Alzheimer’s disease and other neurodegenerative diseases
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1093/brain/awaa276
    Citation Count: 99
  • RESTRICTED
    Title: A novel homozygous KY variant causing a complex neurological disorder
    Journal Name: European Journal of Medical Genetics
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.ejmg.2020.104031
    Citation Count: 2
  • RESTRICTED
    Title: A validation of a self-administered screening test for Parkinson's disease
    Journal Name: Journal of the Neurological Sciences
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.jns.2020.117116
    Best OA location URL:
    Citation Count: 1
  • RESTRICTED
    Title: Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: publisher-specific-oa
    DOI - Digital Object Identifier: 10.1016/s1474-4422(20)30314-8
    Citation Count: 250
  • RESTRICTED
    Title: An Explainable Machine Learning Model for Early Detection of Parkinson's Disease using LIME on DaTSCAN Imagery
    Journal Name: Computers in Biology and Medicine
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.compbiomed.2020.104041
    Citation Count: 114
  • RESTRICTED
    Title: Angiotensin II type 1 receptor blocker telmisartan inhibits the development of transient hypoxia and improves tumour response to radiation
    Journal Name: Cancer Letters
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.canlet.2020.07.015
    Best OA location URL:
    Citation Count: 12
  • RESTRICTED
    Title: Anxiety in Parkinson's disease is associated with changes in the brain fear circuit
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: publisher-specific-oa
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.09.020
    Citation Count: 16
  • RESTRICTED
    Title: Apolipoprotein E isoforms differentially regulate matrix metallopeptidase 9 function in Alzheimer’s disease
    Journal Name: Neurobiology of Aging
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2020.06.018
    Citation Count: 12
  • RESTRICTED
    Title: Cell death and survival pathways in Alzheimer's disease: an integrative hypothesis testing approach utilizing -omic data sets
    Journal Name: Neurobiology of Aging
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2020.06.022
    Citation Count: 23
  • RESTRICTED
    Title: Cell Replacement Therapy in Parkinson’s Disease—History of Development and Prospects for Use in Clinical Practice
    Journal Name: Molecular Biology
    Publisher: Pleiades Publishing Ltd
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1134/s0026893320060060
    Best OA location URL:
    Citation Count: 1
Filters
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.